Literature DB >> 2382740

Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study.

L E Wagenknecht1, G R Cutter, N J Haley, S Sidney, T A Manolio, G H Hughes, D R Jacobs.   

Abstract

Cotinine was measured in the serum of nearly all 5,115 18-30 year old, Black and White, men and women participating in the Coronary Artery Risk Development in (Young) Adults Study, 30 percent of whom reported current cigarette smoking. Ninety-five percent of the reported smokers had serum cotinine levels indicative of smoking (greater than 13 ng/ml). The median cotinine level was higher in Black than White smokers (221 ng/ml versus 170 ng/ml; 95 percent CI for difference: 34, 65) in spite of the fact that estimated daily nicotine exposure and serum thiocyanate were higher in Whites. The difference persisted after controlling for number of cigarettes, nicotine content, frequency of inhalation, weekly sidestream smoke exposure, age, gender, and education. A reporting bias and nicotine intake were ruled out as explanations for the racial difference suggesting that the metabolism of nicotine or the excretion of cotinine may differ by race. Racial differences in cotinine levels may provide clues to the reasons for the observed lower cessation rates and higher rates of some smoking-related cancers in Blacks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382740      PMCID: PMC1404871          DOI: 10.2105/ajph.80.9.1053

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Comparison of smoking-related risk factors among black and white males.

Authors:  T D Sterling; J J Weinkam
Journal:  Am J Ind Med       Date:  1989       Impact factor: 2.214

2.  Elimination from the body of tobacco products by smokers and passive smokers.

Authors:  D W Sepkovic; N J Haley; D Hoffmann
Journal:  JAMA       Date:  1986-08-15       Impact factor: 56.272

3.  Automated method for determining serum thiocyanate, to distinguish smokers from nonsmokers.

Authors:  W C Butts; M Kueheman; G M Widdowson
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

Review 4.  Radioimmunoassay for nicotine and cotinine.

Authors:  H Van Vunakis; H B Gjika; J J Langone
Journal:  IARC Sci Publ       Date:  1987

5.  Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate.

Authors:  N J Haley; C M Axelrad; K A Tilton
Journal:  Am J Public Health       Date:  1983-10       Impact factor: 9.308

Review 6.  Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

Authors:  D Hoffmann; S S Hecht
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

7.  Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease.

Authors:  P Hill; N J Haley; E L Wynder
Journal:  J Chronic Dis       Date:  1983

8.  Serum cotinine as a measure of tobacco smoke exposure in children.

Authors:  E N Pattishall; G L Strope; R A Etzel; R W Helms; N J Haley; F W Denny
Journal:  Am J Dis Child       Date:  1985-11

9.  Nicotine-induced tolerance and receptor changes in four mouse strains.

Authors:  M J Marks; E Romm; D K Gaffney; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

10.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

View more
  88 in total

1.  African-American teen smokers: issues to consider for cessation treatment.

Authors:  E T Moolchan; I Berlin; M L Robinson; J L Cadet
Journal:  J Natl Med Assoc       Date:  2000-12       Impact factor: 1.798

2.  Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation.

Authors:  A Hyland; S Garten; G A Giovino; K M Cummings
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

3.  Measurement and definition for smoking cessation intervention research: the smoke-free families experience. Smoke-Free Families Common Evaluation Measures for Pregnancy and Smoking Cessation Projects Working Group.

Authors:  C L Melvin; P Tucker
Journal:  Tob Control       Date:  2000       Impact factor: 7.552

4.  Mentholated cigarettes and smoking habits in whites and blacks.

Authors:  J E Muscat; J P Richie; S D Stellman
Journal:  Tob Control       Date:  2002-12       Impact factor: 7.552

5.  Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels.

Authors:  L E Wagenknecht; G L Burke; L L Perkins; N J Haley; G D Friedman
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

6.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

7.  Disparities in smoking cessation between African Americans and Whites: 1990-2000.

Authors:  Gary King; Anthony Polednak; Robert B Bendel; My C Vilsaint; Sunny B Nahata
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

8.  Ethnic differences in nicotine exposure.

Authors:  W J McCarthy; N H Caskey; M E Jarvik
Journal:  Am J Public Health       Date:  1992-08       Impact factor: 9.308

Review 9.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Physician- and nurse-assisted smoking cessation in Harlem.

Authors:  J M Royce; A Ashford; K Resnicow; H P Freeman; A A Caesar; M A Orlandi
Journal:  J Natl Med Assoc       Date:  1995-04       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.